Vernakalant hydrochloride for rapid conversion of atrial fibrillation. A phase 3, randomized, placebo-controlled trial

被引：0
|
作者：
Estes, N. A. Mark, III [1 ]
机构：
[1] Tufts Univ, Sch Med, Dept Med, Div Cardiol,New England Cardiac Arrhythmia Ctr, Boston, MA 02111 USA
来源：
HEART RHYTHM | 2008年 / 5卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：906 / 906
页数：1
相关论文
共 50 条
  • [21] Vernakalant: a novel antiarrhythmic drug for the rapid conversion of atrial fibrillation to sinus rhythm
    Hirt, M. N.
    Eschenhagen, T.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2010, 135 (19) : 971 - 976
  • [22] A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy
    Victor, Ronald G.
    Sweeney, H. Lee
    Finkel, Richard
    McDonald, Craig M.
    Byrne, Barry
    Eagle, Michelle
    Goemans, Nathalie
    Vandenborne, Krista
    Dubrovsky, Alberto L.
    Topaloglu, Haluk
    Miceli, M. Carrie
    Furlong, Pat
    Landry, John
    Elashoff, Robert
    Cox, David
    NEUROLOGY, 2017, 89 (17) : 1811 - 1820
  • [23] The efficacy of the pure na channel blocker pilsicainide hydrochloride for cardioversion in patients with persistent atrial fibrillation: A multicenter, randomized, placebo-controlled trial (PSTAF II)
    Okishige, K
    Fukunami, M
    Kumagai, K
    Atarashi, H
    Inoue, H
    CIRCULATION, 2004, 110 (17) : 461 - 461
  • [24] Landiolol hydrochloride for prevention of atrial fibrillation during esophagectomy: a randomized controlled trial
    Aoki, Yoshitaka
    Kawasaki, Yohei
    Ide, Kazuki
    Shimizu, Yuichiro
    Sato, Shinsuke
    Yokoyama, Junichiro
    JA CLINICAL REPORTS, 2020, 6 (01)
  • [25] Landiolol hydrochloride for prevention of atrial fibrillation during esophagectomy: a randomized controlled trial
    Yoshitaka Aoki
    Yohei Kawasaki
    Kazuki Ide
    Yuichiro Shimizu
    Shinsuke Sato
    Junichiro Yokoyama
    JA Clinical Reports, 6
  • [26] IV MAGNESIUM FOR MULTIFOCAL ATRIAL TACHYCARDIA - A RANDOMIZED PLACEBO-CONTROLLED TRIAL
    MCCORD, JK
    BORZAK, S
    DAVIS, T
    SMITH, ST
    GHEORGHIADE, M
    ALEXANDER, M
    CIRCULATION, 1995, 92 (08) : 928 - 928
  • [27] Intravenous propafenone in paroxysmal atrial fibrillation: A randomized, placebo-controlled, double-blind, multicenter clinical trial
    Fresco, C
    Proclemer, A
    Pavan, A
    Bula, G
    Vicentini, A
    Pavan, D
    Morgera, T
    CLINICAL CARDIOLOGY, 1996, 19 (05) : 409 - 412
  • [28] A randomized, double-blind, placebo-controlled comparison of intravenous dofetilide and procainamide in the acute conversion of atrial fibrillation/flutter
    Green, MS
    Dorian, P
    Roy, D
    Sterns, L
    Connolly, SJ
    Ellenbogen, KA
    Coutu, B
    CIRCULATION, 1997, 96 (08) : 2536 - 2536
  • [29] Placebo-Controlled Feasibility Randomized Trial?
    Sanz Rubiales, Alvaro
    Luisa del Valle, Maria
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2014, 48 (01) : E4 - E5
  • [30] Randomized, placebo-controlled trial - Reply
    Kamyabi, Z
    ANNALS OF SAUDI MEDICINE, 2004, 24 (02) : 145 - 145
12345